SaritaDubeyMD

Oncology • San Francisco, CA

Physician

Join to view full profile

Are you Dr. Dubey?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 19 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1600 Divisadero St
San Francisco, CA 94115
Phone+1 415-353-9888

Fax+1 415-353-7150
Is this information wrong?

Summary

Dr. Sarita Dubey, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California.

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2001 - 2003
Hennepin HealthcareResidency, Internal Medicine, 1998 - 2001
Kilpauk Medical CollegeClass of 1994

Certifications & Licensure

CA State Medical License 2006 - 2025

Clinical Trials

Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2005 Dec 01
Terminated
Phase 2
ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Start of enrollment: 2010 Jan 01
Withdrawn
Phase 1

Publications & Presentations

PubMed

79 citations
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomise...
Sumanta Kumar Pal, Robert Uzzo, Jose Antonio Karam, Viraj A Master, Frede Donskov, Cristina Suarez, Laurence Albiges, Brian Rini, Yoshihiko Tomita, Ariel Galapo Kann, ...> ;Lancet. 2022 Oct 1
68 citations
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreate...
Robert J Motzer, Thomas Powles, Michael B Atkins, Bernard Escudier, David F McDermott, Boris Y Alekseev, Jae-Lyun Lee, Cristina Suarez, Daniil Stroyakovskiy, Ugo De Gi...> ;JAMA Oncology. 2022 Feb 1
61 citations
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K. Pal, Bradley Alexander McGregor, Cristina Suárez, Che-Kai Tsao, William Kevin Kelly, Ulka N. Vaishampayan, Lance C. Pagliaro, Benjamin L. Maughan, Yohann Lo...> ;Journal of Clinical Oncology. 2021 Sep 7
17 citations
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-St...
Bonnie S. Glisson, Benjamin Besse, Manuel Cobo Dols, Sarita Dubey, Marco Schupp, Rajul K. Jain, Yizhou Jiang, Hari Menon, Kristiaan Nackaerts, Sergey Orlov, Luis Paz-A...> ;Clinical Lung Cancer. 2017 Nov 1
32 citations
Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression
Min Zhu, Rui Tang, Sameer Doshi, Kelly S. Oliner, Sarita Dubey, Yizhou Jiang, Ross C. Donehower, Timothy Iveson, Elwyn Loh, Yilong Zhang> ;British Journal of Cancer. 2015 Feb 3
211 citations
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label,...
Timothy Iveson, Ross C. Donehower, Irina Davidenko, Sergey Tjulandin, Andrzej Deptala, Mark Harrison, Somanath Nirni, Kuntegowdanahalli C Lakshmaiah, Anne Thomas, Yizh...> ;The Lancet. Oncology. 2014 Aug 1
71 citations
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal c...
Allen Lee Cohn, Josep Tabernero, Juan Maurel, Elżbieta Nowara, Javier Sastre, B.Y.S. Chuah, M.V. Kopp, D.D. Sakaeva, Edith P. Mitchell, Sarita Dubey, S. Suzuki, Y. J. ...> ;Annals of Oncology. 2013 Jul 1
64 citations
Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone
Charles J. Ryan, Mark Rosenthal, Siobhan Ng, Joshi J. Alumkal, Joel Picus, Gwenaelle Gravis, Karim Fizazi, Frederic Forget, Jean-Pascal Machiels, Sandy Srinivas, Min Z...> ;Clinical Cancer Research. 2013 Jan 1
10 citations
ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
Ramesh Gopal, Sarita Dubey, Kenneth E. Rosenzweig, J.Y. Chang, Roy H. Decker, R.M. Gewanter, Feng Ming Kong, Brian E. Lally, Corey J. Langer, Hoon K. Lee, Benjamin Movsas> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Nov 15
84 citations
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
Sarita Dubey, Pasi A. Jänne, Lee M. Krug, Herbert Pang, Xiaofei Wang, Robin Heinze, Colleen Watt, Jeffrey Crawford, Robert A. Kratzke, Everett E. Vokes, Hedy L. Kindler> ;Journal of Thoracic Oncology. 2010 Oct 1
123 citations
Smoking cessation: an integral part of lung cancer treatment.
Janine K. Cataldo, Sarita Dubey, Jodi J. Prochaska> ;Oncology. 2010 Aug 11
Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology
Sarita Dubey, Giorgio V. Scagliotti> ;The Journal of Thoracic and Cardiovascular Surgery. 2009 Oct 1
34 citations
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
Amy Jo Chien, Julie Illi, Andrew H. Ko, Wolfgang Michael Korn, Lawrence Fong, Lee-may Chen, Mohammed Kashani-Sabet, Charles J. Ryan, Jonathan E. Rosenberg, Sarita Dube...> ;Clinical Cancer Research. 2009 Sep 1
42 citations
Update in lung cancer 2008.
Sarita Dubey, Charles A. Powell> ;American Journal of Respiratory and Critical Care Medicine. 2009 May 15
75 citations
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
Anne M. Traynor, Joan H. Schiller, Laura P. Stabile, Jill M. Kolesar, Jens C. Eickhoff, Sanja Dacic, Tien Hoang, Sarita Dubey, Sarah M. Marcotte, Jill M. Siegfried> ;Lung Cancer. 2009 Apr 1
109 citations
Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study
Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff, Jill M. Kolesar, Kathleen Schell, Michael S. Huie, David Groteluschen, Sarah M. Marcotte, Courtney M. Hallahan, Hilary...> ;Journal of Thoracic Oncology. 2009 Apr 1
31 citations
Update in lung cancer 2007.
Sarita Dubey, Charles A. Powell> ;American Journal of Respiratory and Critical Care Medicine. 2008 May 1
5 citations
Update in Lung Cancer 2006
Sarita Dubey, Charles A. Powell> ;American Journal of Respiratory and Critical Care Medicine. 2007 May 1
23 citations
Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
Heather A. Wakelee, Sarita Dubey, David R. Gandara> ;The Oncologist. 2007 Mar 1
33 citations
EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer
Sarita Dubey, Patricia Stephenson, Donna E. Levy, Judith Miller, Steven M. Keller, Joan H. Schiller, David H. Johnson, Jill M. Kolesar> ;Journal of Thoracic Oncology. 2006 Jun 1
41 citations
Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond
Sarita Dubey, Jill M. Siegfried, Anne M. Traynor> ;The Lancet. Oncology. 2006 May 1
2 citations
Phase I study of docetaxel and topotecan in patients with advanced malignancies.
Sarita Dubey, Paul R. Hutson, Dona Alberti, Rhoda Z. Arzoomanian, Kim Binger, Jennifer Volkman, Chris Feierabend, George Wilding, Joan H. Schiller> ;Journal of Oncology Pharmacy Practice. 2005 Dec 1
29 citations
Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab.
Sarita Dubey, Joan H. Schiller> ;The Oncologist. 2005 Apr 1
24 citations
Patient preferences in choosing chemotherapy regimens for advanced non-small cell lung cancer.
Sarita Dubey, Roger L. Brown, Sarah Esmond, Barbara J. Bowers, Janet M Healy, Joan H. Schiller> ;The Journal of Supportive Oncology. 2005 Mar 1
15 citations
Chemotherapy for advanced non–small cell lung cancer
Sarita Dubey, Joan H. Schiller> ;Hematology/oncology Clinics of North America. 2004 Feb 1
Join now to see all